ARCHIVES

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

This article is from The Cancer Letter archive.

Vol. 33 No. 24 | June 22, 2007

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014